Pfizer deal will help expand reach of migraine pill Nurtec Biohaven CEO says – CNBC

Pfizer’s purchase of migraine medication maker Biohaven Pharmaceutical represents a commitment to expand the reach of its calcitonin gene-related peptide (CGRP) franchise, CEO Vlad Coric told CNBC’s … [read more]